You can edit almost every page by Creating an account and confirming your email.

TransMolecular, Inc.

From EverybodyWiki Bios & Wiki


TransMolecular, Inc.
ISIN🆔
IndustryBiotech
Founded 📆
Founder 👔
Headquarters 🏙️,
Area served 🗺️
Members
Number of employees
ParentMorphotek, Inc. (from 2011)
🌐 Websitetransmolecular.com
📇 Address
📞 telephone

TransMolecular was a biotech company located in Birmingham, Alabama. It was geared to finding anti-cancer targeted drugs.[1]

TransMolecular, Inc. engaged in discovering, developing, and commercializing therapies for glioma, metastatic brain tumors, and cancers. It developed TM601, a synthetically-produced polypeptide that was derived from scorpion venom, which is used to specifically target tumors in the treatment of cancer.[2] The company was founded in 1996. In 2003, Fortune Magazine listed the company as one of the 14 "most exciting, innovative companies in the nation".[3][4]

In March 2011, TransMolecular's assets were purchased by Morphotek, a subsidiary of the Japanese pharmaceutical company Eisai.[5]

References

  1. McIntosh, Charlotte (23 Oct 2000). "Hope for brain cancer cure". Birmingham Post-Herald. p. B1.
  2. Kowalczyk, Liz (30 Jan 1999). "Scorpion sting may be cure for brain cancer". The Anniston Star. Anniston, Alabama. p. 4B.
  3. Centers, Jessica (15 Mar 2004). "Technology incubator". The Anniston Star. Anniston, Alabama. p. 1B.
  4. Keeney, Jennifer; Kwon, Beth; Overfelt, Maggie (1 Feb 2003). "14 Hot Startups". CNN Money. Retrieved 21 December 2023.
  5. "Morphotek Acquires TransMolecular's Tumor-Targeting Drug Delivery Assets". Genetic Engineering & Biotechnology News. 5 April 2011. Retrieved 21 December 2023.


This article "TransMolecular" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:TransMolecular. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

Page kept on Wikipedia This page exists already on Wikipedia.